Inventor · disambiguated record
Gagan Bajwa
Also filed as: BAJWA GAGAN
2 granted patents·7 pending applications·0 citations·filing 2019–2025
26Inventor score
Top patents by PatentIndex Score
9 records- 0158US12234473B2CD8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2021·Granted Feb 25, 2025·0 cites·12 claims
- 0258US2025134931A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0357US12377147B2Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab and class 1 restricted t cell receptorsBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Aug 5, 2025·0 cites·14 claims
- 0457US2023348548A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 0555US2024066127A1Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 0654US2025269032A1REPROGRAMMING CD4 T CELLS INTO CYTOTOXIC CD8 CELLS BY FORCED EXPRESSION OF CD8aB AND CLASS 1 RESTRICTED T CELL RECEPTORSBAYLOR COLLEGE MEDICINE·Filed 2025·Application pending·0 cites
- 0754US2023348561A1Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 0850US2022056411A1Methods for isolating cd8+ selected t cellsIMMATICS US INC·Filed 2021·Application pending·0 cites
- 0939US2025146019A1Cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →